title: Fabrication of silver nanoparticles by Phoma glomerata and its combined effect against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus.
abstract: OBJECTIVE
  We report extracellular synthesis of silver nanoparticles (Ag-NPs) from Phoma glomerata and its efficacy against Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa. The bacteria exhibiting resistance to various antibiotics showed remarkable sensitivity, when used in combination of antibiotics and Ag-NPs.
  
  
  RESULTS
  Biosynthesis of Ag-NPs was carried out by challenging the fungal cell filtrate with 1 mmol l(-1) silver nitrate. The Ag-NPs were characterized with the help of UV-Visible spectrophotometer and Fourier transform infrared spectroscopy. Scanning electron microscopy was carried out to detect the size of Ag-NPs. Evaluation of the combined effect(s) was studied by disc diffusion method against E. coli, Staph. aureus and Ps. aeruginosa.
  
  
  CONCLUSIONS
  The biosynthesis route seems to be eco-friendly and easy to scale up the process. Thus, these Ag-NPs may prove as a better candidate for drugs and can potentially eliminate the problem of chemical agents because of their biogenic nature.
  
  
  CONCLUSIONS
  The bacterial resistance against antibiotics has been increasing with alarming rate. To overcome this problem, there is a pressing need to develop bactericidal agents. Ag-NPs may prove to be an answer to drug-resistant bacteria.
authors.affiliation: Department of Biotechnology, S.G.B. Amravati University, Maharashtra, India.
authors.forename: S S
authors.initials: SS
authors.lastname: Birla
authors.forename: V V
authors.initials: VV
authors.lastname: Tiwari
authors.forename: A K
authors.initials: AK
authors.lastname: Gade
authors.forename: A P
authors.initials: AP
authors.lastname: Ingle
authors.forename: A P
authors.initials: AP
authors.lastname: Yadav
authors.forename: M K
authors.initials: MK
authors.lastname: Rai
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001203:Ascomycota / Q000737:chemistry / Q000378:metabolism*; D004926:Escherichia coli / Q000187:drug effects*; D053758:Nanoparticles / Q000737:chemistry / Q000633:toxicity*; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D012834:Silver / Q000737:chemistry / Q000378:metabolism / Q000633:toxicity*; D012835:Silver Nitrate / Q000378:metabolism; D013057:Spectrum Analysis; D013211:Staphylococcus aureus / Q000187:drug effects*
chemical_list: D000900:Anti-Bacterial Agents; D012834:Silver; D012835:Silver Nitrate